584 results on '"Lepage C"'
Search Results
2. FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial
3. Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial
4. Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial
5. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort
6. Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients
7. Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22)
8. Annual cycle of Whitewinged Scoters (Melanitta fusca)in eastern North America: migratory phenology, population delineation, and connectivity
9. Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study
10. The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona
11. Ipsilateral breast cancer recurrence after Deep Inferior Epigastric Perforator (DIEP) flap reconstruction: Incidence and radiological presentation
12. Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)
13. Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
14. Improvement in survival of metastatic colorectal cancer: Are the benefits of clinical trials reproduced in population-based studies?
15. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer
16. 1447P Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study
17. 594P Genetic and transcriptomic analyses of Early-Onset Colon Cancer (EOCC): A post-hoc analysis of 2973 patients (pts) from two adjuvant randomized trials
18. 572P Tolerance of adjuvant chemotherapy in older patients after resection of stage III colon adenocarcinoma from PRODIGE 34 – FFCD 1402 - ADAGE randomized phase III trial
19. 507O Impact of lean body mass-based oxaliplatin dosage on neurotoxicity in adjuvant treatment of stage III colorectal cancer: Final results of the phase II randomized multicenter LEANOX trial
20. 502O Pembrolizumab in combination with CAPOX and bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: Preliminary results of FFCD 1703 POCHI trial
21. Lichenoid eruption during antiPD-L1 immunotherapy with avelumab in metastatic colorectal cancer
22. Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995–2002
23. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells
24. Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis
25. Positive association between cognitive ability and cortical thickness in a representative US sample of healthy 6 to 18 year-olds
26. Non-Pharmaceutical Interventions for Self-Regulatory Failures in Adolescents Suffering from Externalizing Symptoms: A Scoping Review
27. Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial
28. Childhood cognitive ability accounts for associations between cognitive ability and brain cortical thickness in old age
29. Erratum to 'Positive association between cognitive ability and cortical thickness in a representative US sample of healthy 6 to 18 year-olds'
30. LBA77 5-fluorouracil and oxaliplatin with or without docetaxel in the first-line treatment of HER2 negative locally advanced (LA) unresectable or metastatic gastric or gastro-esophageal junction (GEJ) adenocarcinoma (GASTFOX-PRODIGE 51): A randomized phase III trial sponsored by the FFCD
31. 629P First results of the french prospective cohort of colorectal cancers with microsatellite instability (COLOMIN2)
32. 567P Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients: Results from the PETACC 8 study
33. 731P REWENEC: REal-World Evidence in NEC provides a reliable external control arm to avoid randomization for second-line clinical trials - A post hoc proof of concept analysis with the randomized phase II BEVANEC study
34. SO-8 Predictive values of blood-based RNA signature for the FOLFIRINOX/FOLFOX response in advanced pancreatic cancer
35. Multilayer electrophysiological source imaging
36. Incidence and management of malignant digestive endocrine tumours in a well defined French population
37. Patterns of recurrence of obstructing colon cancers after surgery for cure: a population-based study
38. European disparities in malignant digestive endocrine tumours survival
39. Operative mortality after gastric cancer resection and long-term survival differences across Europe
40. Positive association between cognitive ability and cortical thickness in a representative US sample of healthy 6 to 18 year-olds
41. The NIH MRI study of normal brain development: Gender-based differences in correlation of IQ with corticometric measures in healthy children aged 6 to 18
42. Automatic Model-Based Fetal Brain Parcellation to Quantify In Vivo Fetal Brain Development
43. Towards a dataset of 20 ultra-high resolution 3D neurotransmitter receptor atlases
44. Epidemiology and prognosis of synchronous colorectal cancers
45. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population
46. Trends in the management and survival of digestive tract cancers among patients aged over 80 years
47. Is the management of hepatitis C patients appropriate? A population-based study
48. Author's reply: “Management of anal squamous cell carcinoma and its recurrences”
49. LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study
50. LBA28 Prognostic effect of imaging and CEA follow-up in resected colorectal cancer (CRC): Final results and relapse free survival (RFS) - PRODIGE 13 a FFCD phase III trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.